Literature DB >> 27655855

Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population.

Marlies Mulder1,2, Jessica C Kiefte-de Jong1,3, Wil H F Goessens4, Herman de Visser5, Albert Hofman1, Bruno H Stricker6,2,7, Annelies Verbon4.   

Abstract

BACKGROUND: Antimicrobial resistance to ciprofloxacin is rising worldwide, especially in bacteria causing urinary tract infections (UTIs). Prudent use of current antibiotic drugs is therefore necessary.
OBJECTIVES: We analysed (modifiable) risk factors for ciprofloxacin-resistant Escherichia coli.
METHODS: Urinary cultures of UTIs caused by E. coli were collected from participants in the Rotterdam Study, a prospective cohort study in an elderly population, and analysed for susceptibility to ciprofloxacin. Multivariate logistic regression was performed to investigate several possible risk factors for resistance.
RESULTS: Ciprofloxacin resistance in 1080 E. coli isolates was 10.2%. Multivariate analysis showed that higher age (OR 1.03; 95% CI 1.00-1.05) and use of two (OR 5.89; 95% CI 3.45-10.03) and three or more (OR 3.38; 95% CI 1.92-5.97) prescriptions of fluoroquinolones were associated with ciprofloxacin resistance, while no association between fluoroquinolone use more than 1 year before culture and ciprofloxacin resistance could be demonstrated. Furthermore, a high intake of pork (OR 3.68; 95% CI 1.36-9.99) and chicken (OR 2.72; 95% CI 1.08-6.85) and concomitant prescription of calcium supplements (OR 2.51; 95% CI 1.20-5.22) and proton pump inhibitors (OR 2.04; 95% CI 1.18-3.51) were associated with ciprofloxacin resistance.
CONCLUSIONS: Ciprofloxacin resistance in community-acquired UTI was associated with a high intake of pork and chicken and with concomitant prescription of calcium supplements and proton pump inhibitors. Modification of antibiotic use in animals as well as temporarily stopping the prescription of concomitant calcium and proton pump inhibitors need further evaluation as strategies to prevent ciprofloxacin resistance.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27655855     DOI: 10.1093/jac/dkw399

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

1.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

2.  Comparison of approaches for source attribution of ESBL-producing Escherichia coli in Germany.

Authors:  Sara Perestrelo; Guido Correia Carreira; Lars Valentin; Jennie Fischer; Yvonne Pfeifer; Guido Werner; Judith Schmiedel; Linda Falgenhauer; Can Imirzalioglu; Trinad Chakraborty; Annemarie Käsbohrer
Journal:  PLoS One       Date:  2022-07-15       Impact factor: 3.752

3.  Interplay of the Quality of Ciprofloxacin and Antibiotic Resistance in Developing Countries.

Authors:  Deepali Sharma; Rahul P Patel; Syed Tabish R Zaidi; Md Moklesur Rahman Sarker; Qi Ying Lean; Long C Ming
Journal:  Front Pharmacol       Date:  2017-08-21       Impact factor: 5.810

4.  Characteristics of the antibiotic regimen that affect antimicrobial resistance in urinary pathogens.

Authors:  Boudewijn Catry; Katrien Latour; Robin Bruyndonckx; Camellia Diba; Candida Geerdens; Samuel Coenen
Journal:  Antimicrob Resist Infect Control       Date:  2018-06-18       Impact factor: 4.887

5.  What can we learn by examining variations in the use of urine culture in the management of acute cystitis? A retrospective cohort study with linked administrative data in British Columbia, Canada, 2005-2011.

Authors:  Rachel McKay; Michael Law; Kimberlyn McGrail; Robert Balshaw; Romina Reyes; David M Patrick
Journal:  PLoS One       Date:  2019-03-08       Impact factor: 3.240

6.  Objectives, design and main findings until 2020 from the Rotterdam Study.

Authors:  M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2020-05-04       Impact factor: 8.082

7.  Risk factors for quinolone-resistant Escherichia coli infection: a systematic review and meta-analysis.

Authors:  Dong-Mei Zhu; Qiu-Hong Li; Yan Shen; Qin Zhang
Journal:  Antimicrob Resist Infect Control       Date:  2020-01-09       Impact factor: 4.887

8.  Trend analysis of bacterial uropathogens and their susceptibility pattern: A 4-year (2013-2016) study from Aseer region, Saudi Arabia.

Authors:  Abdulaziz Alamri; Mohamed E Hamid; Muhammad Abid; Abdulrahman M Alwahhabi; Khalid M Alqahtani; Mohammed S Alqarni; Mosleh Abomughaid
Journal:  Urol Ann       Date:  2018 Jan-Mar

9.  Fluoroquinolone resistant bacterial isolates from the urinary tract among patients attending hospitals in Bushenyi District, Uganda.

Authors:  Martin Odoki; Adamu Almustapha Aliero; Julius Tibyangye; Josephat Nyabayo Maniga; Emmanuel Eilu; Ibrahim Ntulume; Eddie Wampande; Charles Drago Kato; Ezera Agwu; Joel Bazira
Journal:  Pan Afr Med J       Date:  2020-06-02

10.  Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review.

Authors:  Ann E Stapleton; Florian M E Wagenlehner; Aruni Mulgirigama; Monique Twynholm
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.